{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Stable+Angina+Pectoris", "query": { "condition": "Chronic Stable Angina Pectoris" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 21, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Stable+Angina+Pectoris&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T03:07:32.516Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03789552", "title": "Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Stable Angina Pectoris" ], "interventions": [ { "name": "T89 capsule", "type": "DRUG" }, { "name": "Placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tasly Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 765, "start_date": "2019-08-01", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Naples, Florida", "locations": [ { "city": "Naples", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03789552" }, { "nct_id": "NCT02265796", "title": "Ranolazine Among Unrevascularized Chronic Stable Angina Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Angina" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Sugar pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "North Florida Foundation for Research and Education", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2014-09", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2019-08-22", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02265796" }, { "nct_id": "NCT01659580", "title": "Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Angina Pectoris" ], "interventions": [ { "name": "T89 high dose", "type": "DRUG" }, { "name": "T89 Low dose", "type": "DRUG" }, { "name": "Sanqi+Bingpian", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tasly Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "20 Years to 80 Years" }, "enrollment_count": 1004, "start_date": "2012-08", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2017-03-09", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 30, "location_summary": "Little Rock, Arkansas • Banning, California • La Jolla, California + 22 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Banning", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01659580" }, { "nct_id": "NCT00601302", "title": "Bioequivalency Study of Amlodipine Tablets Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "Chronic Stable Angina", "Vasospastic Angina" ], "interventions": [ { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2004-04", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00601302" }, { "nct_id": "NCT00602017", "title": "Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension", "Chronic Stable Angina", "Vasospastic Angina" ], "interventions": [ { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2004-04", "completion_date": "2004-05", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00602017" }, { "nct_id": "NCT06583395", "title": "Quest to Analyze One Thousand Humans Meditating", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Amyotrophic Lateral Sclerosis (ALS)", "Angina, Stable", "Anxiety", "Asthma", "Atrial Fibrillation", "Cancer Brain", "Cancer, Breast", "Cancer Colon", "Cancer, Lung", "Cancer, Ovarian", "Cancer Prostate", "Cancer Skin", "Throat Cancer", "Lymphoma", "Cancer, Thyroid", "Cancer, Other", "Cerebral Palsy", "Chronic Fatigue Syndrome", "Cluster Headache", "Chronic Obstructive Pulmonary Disease (COPD)", "Chronic Kidney Diseases", "Crohn Disease", "Deafness", "Depression", "Diabetes", "Eczema", "Epilepsy", "Fibroids", "Fibromyalgia", "Heart Failure", "Hypertension", "Hyperthyroidism", "Hypothyroidism", "Irritable Bowel Syndrome (IBS)", "Infertility", "Lyme Disease", "Macular Degeneration", "Migraine", "Multiple Allergies", "Multiple Sclerosis", "Osteoarthritis", "Osteoporosis", "Ovarian Cysts", "Parkinson Disease", "Phantom Limb Pain", "Psoriasis", "Post Traumatic Stress Disorder (PTSD)", "Rheumatoid Arthritis", "Sjogrens Disease", "Spinal Cord Injury", "Spinal Stenosis", "Stroke", "Tension Headache", "Tinnitus", "Ulcerative Colitis" ], "interventions": [ { "name": "Advanced multi-component meditation practice", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Tobias Moeller-Bertram", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 3000, "start_date": "2021-12-05", "completion_date": "2025-03-25", "has_results": false, "last_update_posted_date": "2024-11-01", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Palm Desert, California", "locations": [ { "city": "Palm Desert", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06583395" }, { "nct_id": "NCT01425359", "title": "Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Angina Pectoris", "Coronary Artery Disease", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Ranolazine placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 949, "start_date": "2011-09", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2014-11-04", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Merced, California • Moreno Valley, California + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Merced", "state": "California" }, { "city": "Moreno Valley", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01425359" }, { "nct_id": "NCT03834155", "title": "Enhancing Cardiac Rehabilitation Through Behavioral Nudges", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Myocardial Infarction", "Percutaneous Coronary Intervention", "Coronary Artery Disease", "Valvular Disease", "Chronic Stable Angina", "Chronic Stable Heart Failure" ], "interventions": [ { "name": "Hospital-based CR + Movn Application", "type": "OTHER" }, { "name": "Choice of Hospital or home-based CR + Movn Application", "type": "OTHER" }, { "name": "Hospital-based CR + Movn Application + Nudge", "type": "OTHER" }, { "name": "Choice of Hospital or home-based CR + Movn Application + Nudge", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Denver Health and Hospital Authority", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 447, "start_date": "2019-05-17", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2025-05-13", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03834155" }, { "nct_id": "NCT02423265", "title": "Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Myocardial Ischemia", "Coronary Artery Disease", "Arteriosclerosis", "Chronic Stable Angina" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "East Carolina University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 0, "start_date": "2015-06", "completion_date": "2017-03", "has_results": false, "last_update_posted_date": "2023-03-13", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 1, "location_summary": "Greenville, North Carolina", "locations": [ { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02423265" }, { "nct_id": "NCT05946629", "title": "SELUTION 4 De Novo Small Vessel IDE Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "PCI with SELUTION SLR DCB", "type": "DEVICE" }, { "name": "PCI with FDA approved \"-limus\" DES", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "M.A. Med Alliance S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 960, "start_date": "2023-10-20", "completion_date": "2031-06", "has_results": false, "last_update_posted_date": "2025-09-29", "last_synced_at": "2026-05-22T03:07:32.516Z", "location_count": 43, "location_summary": "Jonesboro, Arkansas • Chula Vista, California • Los Angeles, California + 35 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05946629" } ] }